Summary
Mayne Pharma Group Ltd (Mayne Pharma), formerly Mayne Pharma International Pty Ltd is a healthcare company that develops, manufactures, and commercializes branded and generic medicinal products. The companys products include astrix capsules and tablets, erymax capsules, kapanol capsules, doryx capsules, magnoplasm, and lozanoc and itragerm capsules. It offers services such as product development, analytical development, contract manufacturing, formulation development, logistics, packing services, pre-clinical and clinical development, process development and validation services. Mayne Pharma provides products in the dosage forms of powder, liquid, tablets, capsules, and cream.
GlobalData's Mayne Pharma Group Ltd (MYX) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.
Mayne Pharma Group Ltd Key Recent Developments:
Sep 21,2016: Mayne Pharma Appoints New Director
Jul 29,2016: Mayne Pharma Announces Settlement From Patent Infringement Case
Aug 28,2015: Mayne Pharma Announces US$65M Manufacturing And Development Expansion In USA
Aug 28,2015: Mayne Pharma Reports FY15 Result
Aug 05,2015: Mayne Pharma Appoints Global Leader Of Corporate And Business Development And New CFO Of Mayne Pharma, USA
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
